FluoGuide A/S (FLUO.ST)
FluoGuide A/S
Ole MaalOees Vej 3
Copenhagen 2200
Denmark
45 31 22 66 60
https://fluoguide.com
Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees: 7
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Morten Albrechtsen B.B.A., BBA, M.D. | Chief Executive Officer | N/A | N/A | 1964 |
| Mr. Ole Larsen Cand. merc., M.Sc. | Chief Financial Officer | N/A | N/A | 1965 |
| Prof. Andreas Kjaer M.D., M.Sc., Ph.D. | CSO, Head of Scientific Advisory Board & Director | N/A | N/A | 1963 |
| Dr. Grethe Nørskov Rasmussen M.Sc., Ph.D. | Chief Development Officer | N/A | N/A | 1962 |
| Ms. Dorthe Gronnegaard Mejer | Vice President of Clinical Development | N/A | N/A | N/A |
Description
FluoGuide A/S, a clinical stage biotechnology company, focused on developing drugs for surgical outcomes by making cancer fluorescent in Denmark. Its lead product candidate is FG001, which is in Phase IIa and IIb for the treatment of high-grade glioma; Phase II clinical trial for the treatment of lung cancer, and head and neck cancer. The company also develops FG002, which is in preclinical stage that allows surgeons to differentiate cancer from normal tissue during surgery through a novel uPAR-targeted luminescent technology. It has an agreement with Linköping University Hospital for the development of FG001 that is in the Phase I/II clinical trial for surgical removal of brain cancer; collaboration with Copenhagen University Hospital; collaboration with Intuitive Surgical, Inc. for robotics surgery in head and neck cancer. FluoGuide A/S was incorporated in 2018 and is headquartered in Copenhagen, Denmark.
Corporate Governance
FluoGuide A/S’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
